Speridol

Quick links to important sections

Speridol

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Speridol

What is Speridol? Defining the Medicine

Property Description
Active Ingredient Bisoprolol Fumarate
Form Oral Tablet
Pharmacological Class Cardioselective Beta-Blocker
General Purpose To stabilize and moderate heart activity
Origin Synthetic

What is Speridol and its Active Ingredient?

Speridol is the trade name for a synthetic, single-ingredient, prescription-only pharmaceutical preparation containing the active substance Bisoprolol Fumarate. It is supplied as an oral tablet for administration via the oral route. The chemical structure of Bisoprolol is manufactured in a laboratory, establishing it as a synthetic agent. This precise composition, containing only Bisoprolol, is recognized for its reliable therapeutic properties.


Speridol's Pharmacological Class and Type

Speridol belongs to the drug class known as beta-adrenergic blocking agents, or beta-blockers. It is specifically defined as a second-generation beta1-selective adrenergic receptor antagonist (cardioselective beta-blocker). This cardioselectivity is a key differentiator, as the medicine primarily targets beta1-receptors concentrated in the heart muscle. The clinical recognition of this focused action makes it suitable for scenarios where targeted cardiac moderation is required, such as managing chronic conditions where the heart is subjected to persistent strain.


General Purpose and Function of a Cardioselective Agent

The general purpose of Speridol is to bring stability and efficiency to the heart and circulatory system by reducing excessive physiological stress. The Bisoprolol Fumarate component is recognized for its ability to reduce the heart's workload. The resulting physiological effects involve a reduction in heart rate and a decrease in the strength of heart muscle contraction. The drug's selective action provides foundational benefits by stabilizing cardiac function. Therefore, this medicine's general purpose is centered on moderating the heart's activity to reduce cardiovascular system overload.

What side effects are possible with Speridol?

Possible side effects and safety information for Speridol

The safety profile of Speridol (Bisoprolol Fumarate) is characterized by adverse reactions that are classified by frequency and system-organ class, strictly as documented in official regulatory labeling.

Frequency-Classified Adverse Reactions

Adverse effects are categorized based on their documented occurrence rates:

  • Very Common (ge 1/10): Slowed heart rate (bradycardia), particularly observed in patients with chronic heart failure.
  • Common (ge 1/100 to <1/10): Fatigue, dizziness, headache, gastrointestinal complaints (such as nausea, vomiting, diarrhoea, and constipation), and the sensation of coldness or numbness in the extremities.
  • Uncommon (ge 1/1,000 to <1/100): Sleep disturbances, depression, muscular weakness, and bronchospasm (in patients with pre-existing obstructive airways disease).

Many common effects, including fatigue and headache, are noted in regulatory documents to occur especially at the beginning of the therapy for conditions like hypertension or angina, and often resolve within one to two weeks.

Serious Adverse Reactions and Safety Constraints

The official labeling documents specific reactions of clinical importance:

  • Abrupt Discontinuation Risk: The sudden stopping of therapy, particularly in individuals with coronary artery disease, is associated with a risk of exacerbation of angina pectoris, myocardial infarction, or ventricular arrhythmia.
  • Worsening Heart Failure: A transient or persistent worsening of pre-existing heart failure is a documented risk, especially during the initial dose titration period.
  • Population Cautions: Use in patients with diabetes mellitus may mask the symptoms of acute hypoglycemia. Furthermore, beta-blockers may provoke or worsen psoriasis or similar skin rashes. The use of Speridol in the paediatric population is not recommended due to a lack of available experience.

Overdose and Emergency Response

Speridol Overdose and when to seek help

The official regulatory profile for Speridol (Bisoprolol Fumarate) overdose outlines specific physiological manifestations that may occur following exposure to high doses, requiring mandated emergency intervention.

Documented Overdose Presentations and Actions

Domain Official Regulatory Statement
Documented Manifestations Profound bradycardia (slow heart rate), severe hypotension (low blood pressure), bronchospasm, generalized weakness, and symptoms such as confusion and nausea.
Physiological Systems Affected The Cardiovascular System (leading to shock and worsening heart failure), Central Nervous System (potential for seizures and coma), Respiratory System, and Metabolic System (documented hypoglycemia).
Population Note Low blood sugar (hypoglycemia) is a specific and common manifestation noted in the overdose presentation of children.
Emergency Action Required Seek immediate medical attention. Contact a Poison Control Center immediately.
Urgent Help Needed Immediate medical help is required if symptoms include collapse, seizures/convulsions, severe difficulty breathing, or profound changes in consciousness.

Management and Severity

Official labeling notes that overdose can lead to life-threatening complications. Management is generally symptomatic and supportive. In a clinical setting, this may involve procedures such as activated charcoal administration and the use of intravenous fluids. Continuous monitoring of vital signs and an overnight hospital stay may be required due to the potential for delayed complications.

Therapeutic Uses of Speridol

The use of Speridol (Bisoprolol Fumarate) is centered on providing supportive stabilization for the heart and circulatory system across several conditions characterized by periods of heightened symptoms. The medication is commonly applied in clinical settings marked by persistent cardiac strain and vascular resistance. It is used for managing high blood pressure, is applied in addressing heart failure, and is relevant for easing chest pain caused by angina.

Speridol is widely used for the sustained management of Systemic Hypertension and is crucial supportive therapy for Chronic Heart Failure and Chronic Stable Angina Pectoris. The medicine helps address symptom clusters that may become intense or disruptive, particularly those related to an over-active or strained heart.

“Its role includes support for long-term functional stability and is relevant for easing the symptomatic burden during periods of physical exertion.”

Speridol is relevant for easing symptoms related to cardiac strain, offering supportive relief that is relevant for managing symptoms that interfere with daily comfort and supports the patient during periods of physical exertion. For those with Chronic Heart Failure, it may assist with managing the distressing manifestations of the condition, such as exercise intolerance and fatigue. Its use may assist with maintaining a sense of stability when symptoms are more noticeable.


Quick Fact: Relief for Cardiac Strain Speridol supports the heart and circulatory system to address symptoms that create noticeable physiological strain, helps with long-term management of conditions like high blood pressure and stable angina.

Eligibility and Restrictions for Use

Speridol (Bisoprolol Fumarate) eligibility is strictly defined by regulatory authorities based on cardiac status, concurrent conditions, and specific populations.

Eligibility Classification Population / Condition
Absolute Contraindication Cardiogenic shock, acute or worsening heart failure, marked sinus bradycardia (slow heart rate), second or third-degree AV block (without pacemaker), and severe asthma or severe COPD.
Contraindication Hypersensitivity to Bisoprolol Fumarate or any product component.

The medicine is generally restricted in certain populations. Use is not recommended in pediatric patients (children and adolescents) as safety and effectiveness have not been established. Speridol is also not recommended during pregnancy or lactation, as the regulatory benefit-risk assessment suggests potential risk to the fetus or nursing infant.

Special caution and close monitoring are required for patients with severe hepatic impairment (liver dysfunction) or severe renal impairment (kidney dysfunction). The drug is also used with caution in patients with diabetes, Prinzmetal’s angina, or a history of psoriasis, as specified in the official labeling.

What should I know about interactions with other medicines?

Speridol (Bisoprolol Fumarate) has an officially documented interaction profile centered on pharmacodynamic and pharmacokinetic constraints outlined in regulatory labels.

Prohibited and Restricted Combinations

Co-administration with Floctafenine and Sultopride is formally contraindicated. Combinations with other systemic beta-blockers (including topical eye drops) are restricted due to the risk of additive systemic beta-blockade. The use of Calcium Antagonists of the Verapamil or Diltiazem types, as well as Class I Antiarrhythmics (e.g., Quinidine, Flecainide), is generally not recommended due to a documented negative influence on heart contractility and electrical conduction.

Pharmacodynamic Effects

Co-administration with Centrally-acting Antihypertensives (e.g., Clonidine) may lead to a reduction of heart rate and cardiac output. Non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the blood pressure-lowering effect of Speridol. For patients receiving Insulin or oral antidiabetic drugs, Speridol can increase the blood sugar-lowering effect and may officially mask typical symptoms of hypoglycemia, such as a fast heartbeat.

Exposure and Timing Rules

The concurrent use of Rifampicin is documented to increase the metabolic clearance of Speridol, resulting in a shortened elimination half-life. If therapy with a centrally-acting antihypertensive like Clonidine is to be discontinued, Speridol must be withdrawn several days prior to the withdrawal of the other agent. Speridol absorption is unaffected by food intake, but simultaneous use of Alcohol may result in additive blood pressure-lowering effects.

Mechanism of Action

Selective Blockade of Cardiac beta1-Receptors

The drug's primary action involves competitive antagonism of the beta1-adrenergic receptors (beta1-AR) found mainly on heart tissue. By blocking these receptors, Speridol prevents the binding of catecholamines (like norepinephrine) that stimulate the heart under stress, which reduces the excitatory signals from the sympathetic nervous system (SNS) and initiates a mechanism of negative chronotropy (slowing heart rate) and negative inotropy (reducing contraction force).

Modulating the Intracellular Signaling Cascade

The beta1-AR blockade triggers an important intracellular cascade by suppressing the activity of the enzyme adenylyl cyclase. This leads to reduced levels of the second messenger cAMP and, consequently, decreased influx of calcium ions ( Ca^2+) into myocardial cells. This modification of the cellular calcium dynamic is the direct physiological process that results in the lowered heart rate and reduced contractility, modulating cardiac function.

Systemic Influence via the RAAS Pathway

Speridol's mechanism also influences systemic circulatory pathways by blocking beta1-ARs located on the juxtaglomerular cells in the kidneys. This peripheral action suppresses the release of renin, the enzyme responsible for initiating the Renin-Angiotensin-Aldosterone System (RAAS) cascade. By intervening at this early initiation point, the mechanism modulates the activity of this blood pressure-regulating system.

Dosage and Administration Information

Speridol (Bisoprolol Fumarate) is exclusively administered via the oral route as a tablet. The medicine is generally taken once daily in the morning and may be ingested with or without food. If a scheduled dose is missed, standard administration guidelines indicate that the patient should continue with the next scheduled dose and must not take a double dose to compensate.

The principles of its use are determined by the specific condition being managed. For Hypertension and Stable Angina Pectoris, the typical starting dose is 5 mg once daily, which may be adjusted up to a maximum dose of 20 mg once daily.

The administration protocol for Chronic Stable Heart Failure (CHF) is distinct and requires a phase of monitored dose titration. Treatment initiation begins with a low dose of 1.25 mg once daily, and the dose is then slowly doubled at controlled intervals, advancing up to a target maximum of 10 mg once daily.

Usage Condition Administration Protocol General Limitation
Discontinuation Requires the dose to be gradually reduced (tapered) over one to two weeks. Abrupt cessation must be avoided.
Severe Organ Impairment The daily dose is generally restricted to a maximum of 10 mg for patients with severe hepatic or renal dysfunction. Max 10 mg once daily.
Pediatric Population The use of this medicine is not recommended, as data confirming safety and efficacy in children are not established. Use not recommended.

The overall pattern of use is defined as long-term therapy for chronic conditions.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Speridol

Evidence from Clinical Studies for Chronic Heart Failure

The research available for Speridol, which is often known as Bisoprolol Fumarate, has focused on large-scale, randomized controlled trials (RCTs). The research has focused on Adults who have stable Chronic Heart Failure and a specific type of heart dysfunction called reduced ejection fraction (HFrEF).

Researchers explored long-term patient outcomes, which included measuring all-cause mortality (the total number of deaths in the study group) and the frequency of hospital admissions over defined time intervals. Studies also monitored changes in the heart's function. The findings describe patterns observed in these study populations, which reflect how specific outcomes related to systemic or functional imbalance were measured across the study period, during which the medicine was administered alongside other existing treatments.

Evidence from Clinical Studies for Systemic Hypertension

For the indication of Systemic Hypertension (high blood pressure), research primarily utilizes Randomized Controlled Trials (RCTs). These studies focused on Adults with common forms of high blood pressure.

The main outcomes researchers monitored included precise measurements of changes in both Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP), and changes in Resting Heart Rate (RHR). Long-term studies also examined the occurrence of major cardiovascular events in these populations. The data show patterns related to how blood pressure and heart rate measurements evolved in the observed populations.

Evidence from Clinical Studies for Chronic Stable Angina Pectoris

In the context of Chronic Stable Angina Pectoris (chest pain due to cardiac strain), research has included both Randomized Controlled Trials (RCTs) and data collected from real-world observational settings.

Studies examined how symptoms evolved in the observed populations by measuring the frequency of angina episodes (a patient-reported outcome describing perceived discomfort) and changes in the use of short-acting nitrates. Research also described patterns related to functional measures, such as exercise capacity and activity level. Findings indicate that changes were measured during the study period for outcomes related to physical discomfort and daily functioning.

What is Still Uncertain About Speridol Research

Evidence is limited in several areas. Comparative evidence is lacking for certain groups, such as those with highly resistant hypertension. Data for certain groups, including those with significant organ impairment, remain insufficient. The overall certainty remains low for populations that were excluded from the main regulatory trials, such as those with unstable or acute cardiovascular conditions.

Frequently Asked Questions (FAQ)

Common questions about Speridol (FAQ)


Q: What is the main difference between Speridol and similar medicines?

Speridol is classified as a highly selective beta-1 adrenergic receptor blocking agent, a classification often referred to as cardioselective. Official documents describe that its primary action is concentrated on beta-1 receptors, which are found mainly in heart tissue. This focused classification indicates its mechanism of action on the heart and circulatory system.


Q: Is Speridol a type of pain reliever?

No. Speridol is classified as a cardioselective beta-blocker, and its general purpose is to moderate heart activity and reduce its workload in chronic conditions such as hypertension and heart failure. It is not classified as an analgesic (a general pain reliever) in official regulatory documentation.


Q: Does Speridol help with general anxiety?

Speridol is not indicated for the treatment of general anxiety disorder. However, official safety documents indicate that 'anxiety' or 'restlessness' has been listed among the reported adverse psychiatric reactions.


Q: How long does the effect of one dose of Speridol last?

The elimination half-life of the active ingredient is typically reported to be between 10 and 12 hours. This long half-life supports the usual regimen of taking the medicine once a day.


Q: Are there any long-term side effects connected to using Speridol?

Official safety documents note common effects, such as fatigue and headache, which often resolve early in therapy. These documents also emphasize that one of the serious risks of long-term therapy is associated with the abrupt stopping of the medicine, which can worsen existing heart conditions.


Q: Does Speridol cause weight gain?

Weight gain is not reported as a common adverse reaction in the official regulatory documentation for Speridol.


Q: Can I drink coffee or caffeine while taking Speridol?

Regulatory information advises caution regarding substances that affect heart rate and blood pressure. Since caffeine can stimulate the heart, it may counteract the effects of beta-blockers. Regulatory information suggests that monitoring consumption of caffeine-containing products may be relevant.


Q: What over-the-counter medicines should I check before taking with Speridol?

Official interaction warnings focus on systemic beta-blockers, certain Calcium Antagonists, Class I Antiarrhythmics, Centrally-acting Antihypertensives, and Non-steroidal Anti-inflammatory Drugs (NSAIDs).


Q: Is Speridol safe for older adults to use?

Clinical trials for conditions like heart failure specifically included and studied elderly patients (aged 65 years and older). This evidence supports the medicine's documented use in this population, which requires appropriate medical supervision.


Q: What is the maximum amount of time someone can safely use Speridol?

Speridol is approved for the long-term management of chronic conditions such as hypertension and chronic heart failure. Official documents do not specify a maximum duration for treatment.


Q: Are there any foods or drinks I should avoid while on Speridol?

The medicine can typically be ingested with or without food as its absorption is generally unaffected. However, the simultaneous use of alcohol is documented to potentially cause additive blood pressure-lowering effects.


Q: Is Speridol known to be addictive or habit-forming?

No. Bisoprolol Fumarate, the active ingredient in Speridol, is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA) and is not known to be addictive or habit-forming.


Q: What does 'contraindicated' mean in relation to Speridol?

A contraindication is a condition or circumstance that makes the use of the medicine potentially harmful and therefore formally prohibited by regulatory authorities. For Speridol, examples include acute heart failure and certain types of slow heart rates.


Q: Is there a generic version of Speridol available?

Yes, a generic version of the medicine, Bisoprolol Fumarate, is available.


Q: How does Speridol compare to similar treatments in terms of reported side effects?

Official regulatory summaries state that comparative evidence is often insufficient or lacking for specific patient groups or clinical scenarios. Any comparison of side effects or outcomes should be discussed with a healthcare provider.


Q: What are the different strengths or forms Speridol comes in?

Speridol is supplied as an oral tablet in multiple strengths for administration. Regulatory documents indicate that available strengths include 1.25 mg, 2.5 mg, 5 mg, and 10 mg.


Q: Do I need any specific medical tests before starting Speridol?

Regulatory information requires caution and close monitoring, especially when initiating therapy for heart failure or in patients with severe organ impairment. This level of supervision generally requires medical tests to assess the patient’s baseline health and monitor for changes.


Q: Can Speridol be taken with antacids or heartburn medication?

Some antacids that contain calcium carbonate may potentially decrease the medicine's effectiveness. Regulatory data suggests that the administration of the antacid and Speridol may require separation in timing due to this potential effect.


Q: Is it normal to have vivid dreams when taking Speridol?

'Vivid dreams' is listed among the documented, though uncommon, adverse psychiatric reactions in official safety documentation.


Q: Does Speridol cause dry mouth?

Dry mouth (xerostomia) is reported as a documented adverse experience in official safety data, typically listed under autonomic nervous system effects.


Q: Can Speridol make my skin more sensitive to the sun?

Official labeling for beta-blockers indicates that the medicine may make the skin more sensitive to light from the sun or sunlamps, a condition known as photosensitivity.


Q: How is Speridol different from a supplement for a similar problem?

Speridol is a synthetic, single-ingredient, prescription-only pharmaceutical containing Bisoprolol Fumarate. It is highly regulated and classified as a cardioselective beta-blocker, distinguishing it from over-the-counter supplements.


Q: What are the main reasons people stop taking Speridol?

Official safety reports document that the most common reasons patients stopped the medicine in clinical trials included adverse reactions such as fatigue, slow heart rate (bradycardia), dizziness, and a worsening of pre-existing heart failure.


Q: What does the box warning or 'black box' warning on Speridol mean?

The medicine carries a prominent warning, often referred to as a Boxed Warning, which is emphasized by the FDA. This warning specifically concerns the risk of worsening heart conditions, such as angina or a heart attack, if the medicine is stopped suddenly.


Q: Can Speridol cause changes in mood or behavior?

Official documents list 'depression,' 'anxiety/restlessness,' and 'sleep disturbances' among the documented psychiatric adverse reactions.


Q: Why do official documents emphasize talking to a doctor about certain pre-existing conditions before using Speridol?

Official warnings exist to support the appropriate use of the medicine. Conditions like diabetes, severe organ impairment, or a history of asthma require specialized monitoring and caution because these conditions can be significantly affected by the medicine.


Q: Has Speridol been approved in countries outside of the US?

The active ingredient, Bisoprolol Fumarate, has official documentation published by regulatory bodies in multiple regions, including the European Medicines Agency (EMA), confirming its approval and use internationally.


Q: Are there warnings about driving or operating machinery while taking Speridol?

Yes. Because side effects like dizziness, fatigue, and drowsiness can occur, especially at the start of treatment, caution is advised in official labeling when driving or operating machinery.


Q: What should I do if I feel dizzy after taking Speridol?

Dizziness is listed as a common side effect, particularly when therapy begins. Official labeling advises caution when operating machinery until the response to the medicine is known, as symptoms may be temporary.


Q: Why is Speridol sometimes prescribed for conditions other than the main ones listed?

The official regulatory label strictly outlines the uses (indications) for which the medicine has been formally tested and approved, such as hypertension, angina, and chronic stable heart failure. Official documents do not contain information on uses outside of these indications.


Q: Can people with liver or kidney issues take Speridol?

Yes, but with restrictions. For individuals with severe hepatic (liver) or renal (kidney) dysfunction, official regulatory information specifies that the daily dose is typically restricted to a maximum of 10 mg under medical supervision.

How should Speridol be stored and disposed of?

Official Storage and Disposal Requirements

Maintaining the quality and safety of Speridol (Bisoprolol Fumarate) requires adherence to specific regulatory requirements for storage and disposal, primarily focused on environmental protection and product integrity.

Requirement Area Official Instructions
Temperature & Light Store at 20 C to 25 C (Controlled Room Temperature), and dispense in tight, light-resistant containers to protect the tablets.
Container & Stability Storage must be in the original package. For bottle packs, the medicine is stable for 6 months after the first opening.
Child Safety Keep this medicine out of the sight and reach of children.
Disposal Rules Dispose of any unused or expired tablets in accordance with local requirements. The medicine should not be thrown away via wastewater or flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Speridol found in:

A-Z Index: